Analgesic Efficacy of Genicular Nerve Block Versus (IPack Block ) in Patients Undergoing (ACL) Repair

Not Applicable

Recruiting

• Conditions: Post Operative Pain
• Interventions: Procedure: Genicular nerve block

• Registration Number: NCT06404658
• Lead Sponsor: Beni-Suef University

Brief Summary

One of the most common injuries to the knee is an anterior cruciate ligament (ACL) sprain or tear due to trauma ACL damage is crippling and often requires repair with an arthroscopic method, which is an outpatient surgery. Nevertheless, patients experience severe postoperative pain on the first day after the ACL reconstruction.Efficient postsurgery pain management is an important part of patient recovery that is also crucial for their satisfaction.

Detailed Description

The optimum role of peripheral nerve blocks in ACL reconstruction continue to be debated as a component of multi-modal analgesia . As such ,an ideal block for ACLR would target sensation but not motor function,have minimal complication risk,and be easily reproducible The genicular nerves include branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves which innervate the knee capsule . The superolateral, superomedial, and inferomedial On the other hand, the interspace between the Popliteal Artery and Capsule of the Knee (IPACK) block provides analgesia on the posterior knee joint, and the application of a genicular or IPACK block has been be associated with promising outcomes following the ACLR surgery

Study Timeline

• Study First Submitted: 2024-04-08
• Status Verified: 2024-05
• Study First Submitted QC: 2024-05-04
• Study First Posted: 2024-05-08
• Study Start: 2024-05-12
• Last Update Submitted: 2024-05-12
• Last Update Posted: 2024-05-14
• Primary Completion: 2024-10-30
• Study Completion: 2024-10-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Patient age from 18 to 45 years old Patient status ASA I - II Patient body mass index (BMI) <40 kg/m2

Exclusion Criteria

• -Patients were excluded if they refused consent.
• Patients who are Not cooperative.
• BMI >40 kg/m2.
• Allergy to local anesthetics.
• Patients with anticoagulation or bleeding problems.
• Previous nerve dysfunction.
• Physical status ASA class IV.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Genicular nerve block	Genicular nerve block	patients who receive Genicular nerve block with spinal anathesia .
IPACK block	Genicular nerve block	patients who receive IPACK block with spinal anathesia.

Primary Outcome Measures

Name	Time	Method
VAS score	48 hour	Measuring pain intensity regarding mean visual analogue score (VAS score ) ranging from 0 (no pain) to 10 (the worst imaginable pain.

Secondary Outcome Measures

Name	Time	Method
Incidence of occurrence of systemic toxicity	Within 24 hour	( hypotension ,arrthymias, bradycardia, cardiac arrest, oral numbness and convulsions
The length of hospital stay .	within one week	The length of hospital stay .
Ambulatory score	Within 48 hour	Ambulatory score from ( 0 to 2) (score of 0) is assigned if the activity cannot be performed despite substantial help; (score of 1 )is assigned if the activity is performed using personal physical support.; (score of 2) is assigned if the activity is performed independently.
Time of first rescue analgesia	within 24 hour	the time to ask for the first post operative analgesia
Total opioid consumption post operative	Within 24 hour	Total opioid consumption post operative

Trial Locations

Locations (1)

Benisuef University Hospital; 🇪🇬 Benisuef, Egypt